SCHEMBL19617804

SCHEMBL19617804

O=C(c1ccccc1S(=O)(=O)C1CCCCC1)N1CCN(c2nc3ccc(F)cc3s2)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 18/20 1.00
TP53 P04637 2/20 0.59
MAPT P10636 1/20 0.59
LMNA P02545 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30607198 1.00 NAAA (1.00) NAAATP53MAPTLMNA
SCHEMBL21050112 0.99 NAAA (1.00) NAAATP53MAPTLMNA
SCHEMBL30607181 0.97 NAAA (1.00) NAAATP53MAPTLMNA
SCHEMBL19630537 0.97 NAAA (1.00) NAAATP53MAPTLMNA
SCHEMBL19630607 0.95 NAAA (1.00) NAAATP53MAPTLMNA
SCHEMBL30607207 0.95 NAAA (1.00) NAAATP53MAPTLMNA
SCHEMBL19630620 0.93 NAAA (0.88) NAAATP53MAPT
SCHEMBL19630612 0.91 NAAA (0.88) NAAATP53MAPTLMNA
SCHEMBL26836407 0.89 NAAA (0.81) NAAATP53MAPT
SCHEMBL19630606 0.89 NAAA (1.00) NAAATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458447-B1 PIPERAZINYL METHANONE NAAA INHIBITORS UNIV CALIFORNIA (US) 2023-11-29 EP disclosed
EP-3458447-B1 PIPERAZINYL METHANONE NAAA INHIBITORS UNIV CALIFORNIA (US) 2023-11-29 EP disclosed
US-10556892-B2 Piperazinyl methanone NAAA inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-02-11 US disclosed
US-10556892-B2 Piperazinyl methanone NAAA inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-02-11 US disclosed
US-20190177313-A1 PIPERZINYL METHANONE NAAA INHIBITORS FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2019-06-13 US disclosed
US-20190177313-A1 PIPERZINYL METHANONE NAAA INHIBITORS FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2019-06-13 US disclosed
EP-3458447-A1 PIPERAZINYL METHANONE NAAA INHIBITORS The Regents of The University of California (US) 2019-03-27 EP disclosed
WO-2017201103-A1 PIPERAZINYL METHANONE NAAA INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-23 WO disclosed
WO-2017201103-A1 PIPERAZINYL METHANONE NAAA INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177313-A1 PIPERZINYL METHANONE NAAA INHIBITORS NAAA, NAA15, NAA50 NAAA 1/4885TP53 4751/4885MAPT 642/4885
US-10556892-B2 Piperazinyl methanone NAAA inhibitors NAAA, NAA50, NAA15 NAAA 1/4885TP53 4650/4885MAPT 884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.